In our study, the treatment with sEV secreted by murine BM-MSC, independent of physical activity, showed a decrease in the levels of TGF-β1 in the rats submitted to UUO, suggesting that sEV-treatment can contribute to the reduction of renal fibrosis via TGF-β1. The gene discussed is TGFB1; the disease is renal fibrosis.